Share
  • Facebook
  • Twitter
  • Linked In
  • Google+
back top
NICE (National Institute for Clinical Excellence) Guidance on ACI

1300 members from 70 countries Join ICRS

News

Clinical trial evidence shows that ACI can improve the symptoms of articular cartilage defects of the knee. There is evidence that it is likely to be more successful in people who haven’t had any previous knee repair surgery, and in people who have very little osteoarthritic damage in the knee. But, it is unclear how well ACI works in the long term compared with microfracture, the most commonly used alternative treatment.

NICE (National Institute for Clinical Excellence) Guidance on ACI

NICE (National Institute for Clinical Excellence) Guidance on ACI

06/10/2017

It is an enormous pleasure to welcome over 150 participants from 31 countries and from all 4 corners of the world. We do have confirmed participants from Austria, Bangladesh, Belgium, Brazil, Canada, Chile, Croatia, Denmark, Ecuador, Estonia, France, Germany, Greece, India, Ireland, Italy, South Korea, Malaysia, Mexico, Netherlands, Oman, Poland, Qatar, Russian Federation, Slovenia, Spain, Switzerland, Turkey, UAE, United Kingdom & United States of America – a truly international event!

ICRS Focus Meeting Osteoarthritis in the Athlete

ICRS Focus Meeting Osteoarthritis in the Athlete

08/09/2017

Vericel (Nasdaq: VCEL), a specialty biologics company with three approved cellular therapy products on the market might still be underappreciated by investors after its recent run?

Vericel (VCEL): Revenue Growth Fueled by Three Cellular Therapies

Vericel (VCEL): Revenue Growth Fueled by Three Cellular Therapies

01/09/2017